Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Efficacy and Safety of PZ01 Treatment in Patients With r/r CD19+ B-cell Acute Lymphoblastic Leukemia/B Cell Lymphoma
ClinicalTrials.gov study NCT03281551. IPD Sharing: NO. Countries: 1. Publications: 0.
Study for Validation of Target Therapy in Multiple Myeloma Cells From Patients With miRNAs Released From B Cells, and Study of the Bone Marrow Tumor Microenvironment (Microenvironment of MM)
ClinicalTrials.gov study NCT06154317. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT04739813. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Novel Anti-CD19 CAR-T in Patients With r/r B-Cell Malignancies
ClinicalTrials.gov study NCT05932173. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment
ClinicalTrials.gov study NCT03505762. IPD Sharing: Not stated. Countries: 1. Publications: 0.
B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021
ClinicalTrials.gov study NCT05518383. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms
ClinicalTrials.gov study NCT06593145. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Glofitamab for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma
ClinicalTrials.gov study NCT06956092. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL
ClinicalTrials.gov study NCT05360238. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
ClinicalTrials.gov study NCT05139017. IPD Sharing: YES. Countries: 24. Publications: 0.
A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies
ClinicalTrials.gov study NCT04532281. IPD Sharing: NO. Countries: 1. Publications: 0.
Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01045928. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ribomustin in the Second Line Therapy of Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02072967. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Modelling the Interaction Between Synthetic Model Immunogens and the Induced B and T Cell Repertoires.
ClinicalTrials.gov study NCT04046978. IPD Sharing: NO. Countries: 1. Publications: 0.
Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma
ClinicalTrials.gov study NCT00644124. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL
ClinicalTrials.gov study NCT06863259. IPD Sharing: YES. Countries: 1. Publications: 0.
Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT06793241. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Oncolytic Vaccinia VIrus Delivering Targeted CD19 in Vivo CAR-T/M Therapy for Refractory/Relapsed B-cell Lymphoma
ClinicalTrials.gov study NCT07398963. IPD Sharing: NO. Countries: 1. Publications: 0.
Mapping B-cell Biology Across the Cardiovascular Territories of Giant Cell Arteritis: Towards a New Therapeutic Approach (RituxiMAP GCA)
ClinicalTrials.gov study NCT07269938. IPD Sharing: NO. Countries: 1. Publications: 0.
A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
ClinicalTrials.gov study NCT04332822. IPD Sharing: Not stated. Countries: 7. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.